Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brekke

Showing results (911-920 of 947) with videos related to

Pageof 95
Sort By:
Thrombosis Research|September 12, 2020
Thrombosis and bleedings in a cohort of cancer patients treated with apixaban for venous thromboembolismTrine-Lise Hannevik, Jorunn Brekke, Tone Enden, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 12, 2021
A Conformational Change of Complement C5 Is Required for Thrombin-Mediated Cleavage, Revealed by a Novel Ex Vivo Human Whole Blood Model Preserving Full Thrombin ActivityPer H Nilsson, Christina Johnson, Quang Huy Quach, et al.
Atherosclerosis|February 25, 2026
Extensive pregnancy-related off-treatment time in women with familial hypercholesterolaemiaMarianne Klevmoen, Jeanine Roeters van Lennep, Martin Prøven Bogsrud, et al.
Circulation|November 13, 2004
Syncope Evaluation in the Emergency Department Study (SEEDS): a multidisciplinary approach to syncope managementWin K Shen, Wyatt W Decker, Peter A Smars, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 18, 2010
Genomic changes in chromosomes 10, 16, and X in malignant peripheral nerve sheath tumors identify a high-risk patient groupHelge R Brekke, Franclim R Ribeiro, Matthias Kolberg, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 25, 2013
Chimeric anti-CD14 IGG2/4 Hybrid antibodies for therapeutic intervention in pig and human models of inflammationCorinna Lau, Kristin S Gunnarsen, Lene S Høydahl, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|November 15, 2022
The genetic risk factor CEL-HYB1 causes proteotoxicity and chronic pancreatitis in miceKarianne Fjeld, Anny Gravdal, Ranveig S Brekke, et al.
Acta Physiologica (Oxford, England)|April 21, 2016
Increased microvascular permeability in mice lacking Epac1 (Rapgef3)R K Kopperud, C Brekke Rygh, T V Karlsen, et al.
Brain Communications|February 27, 2026
Increased cerebrospinal fluid YKL-40 concentration in hip fracture patients with deliriumThea Berntsen, Kaj Blennow, Henrik Zetterberg, et al.
Thrombosis Research|June 16, 2023
Arterial events in cancer patients treated with apixaban for venous thrombosisTrine-Lise Larsen, Marte Svalastoga, Jorunn Brekke, et al.
Pageof 95

Showing results (911-920 of 947) with videos related to

Sort By:
Pageof 95
Thrombosis Research|September 12, 2020
Thrombosis and bleedings in a cohort of cancer patients treated with apixaban for venous thromboembolismTrine-Lise Hannevik, Jorunn Brekke, Tone Enden, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 12, 2021
A Conformational Change of Complement C5 Is Required for Thrombin-Mediated Cleavage, Revealed by a Novel Ex Vivo Human Whole Blood Model Preserving Full Thrombin ActivityPer H Nilsson, Christina Johnson, Quang Huy Quach, et al.
Atherosclerosis|February 25, 2026
Extensive pregnancy-related off-treatment time in women with familial hypercholesterolaemiaMarianne Klevmoen, Jeanine Roeters van Lennep, Martin Prøven Bogsrud, et al.
Circulation|November 13, 2004
Syncope Evaluation in the Emergency Department Study (SEEDS): a multidisciplinary approach to syncope managementWin K Shen, Wyatt W Decker, Peter A Smars, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 18, 2010
Genomic changes in chromosomes 10, 16, and X in malignant peripheral nerve sheath tumors identify a high-risk patient groupHelge R Brekke, Franclim R Ribeiro, Matthias Kolberg, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 25, 2013
Chimeric anti-CD14 IGG2/4 Hybrid antibodies for therapeutic intervention in pig and human models of inflammationCorinna Lau, Kristin S Gunnarsen, Lene S Høydahl, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|November 15, 2022
The genetic risk factor CEL-HYB1 causes proteotoxicity and chronic pancreatitis in miceKarianne Fjeld, Anny Gravdal, Ranveig S Brekke, et al.
Acta Physiologica (Oxford, England)|April 21, 2016
Increased microvascular permeability in mice lacking Epac1 (Rapgef3)R K Kopperud, C Brekke Rygh, T V Karlsen, et al.
Brain Communications|February 27, 2026
Increased cerebrospinal fluid YKL-40 concentration in hip fracture patients with deliriumThea Berntsen, Kaj Blennow, Henrik Zetterberg, et al.
Thrombosis Research|June 16, 2023
Arterial events in cancer patients treated with apixaban for venous thrombosisTrine-Lise Larsen, Marte Svalastoga, Jorunn Brekke, et al.
Pageof 95